MedTrace Logo

Act With Nature: Promoting Planetary Well-being

NCT06548243 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2025-04-01

No results posted yet for this study

Summary

The research investigates the effects of nature-based programme (Act with Nature; AWN) in promoting psychological well-being and pro-environmental behaviour among working age participants in Finland. Our research deepens understanding of how coping with environment-related emotions and nature connectedness are connected to human wellbeing and pro-environmental behaviour. The psychological wellbeing and pro-environmental behaviour are investigated with self-report measures and analysed with quantitative and qualitative methods. The project will provide a new programme (AWN) for combining individual well-being and behaviour change. The results can provide a theoretical framework and working model for health professionals to intervene and support people in adapting to environmental crises and coping with stress.

Conditions

  • Well-Being, Psychological

Interventions

BEHAVIORAL

Act with Nature Programme

The participants in the intervention group are offered a 12-week nature-based programme, which includes independent exercises and information on an online learning environment, as well as online or in-person group meetings.

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER

  • University of Surrey

    collaborator OTHER

  • JAMK University Of Applied Sciences

    lead OTHER

Principal Investigators

  • Katriina Hyvönen, PhD · JAMK University Of Applied Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06548243 on ClinicalTrials.gov